The latest prostate cancer news
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according…
Addition of abiraterone acetate plus prednisone shows clear survival improvements in castration-sensitive prostate cancer Two…
A study published in Cancer Research introduces Differential Subclone Eradication and Resistance Analysis (DSER), an approach developed…
Results from the ARCHES study, presented at the European Society for Medical Oncology (ESMO) Congress 2021,…
Icon Group have announced the interim results of a first-of-its-kind study, PINPOINT, which shows that…
Advanced radiotherapy technology can safely deliver curative treatment for prostate cancer patients in as few…
Prostate cancer is the most common male cancer and approximately 5,000 Finnish men are diagnosed…
In a recent study, researchers highlighted immediate cardiopulmonary risks associated with patients undergoing minimally invasive…
South Australian medical researchers have identified a new way in which prostate cancer cells use…
The relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer…